Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11


EDEN PRAIRIE, Minn., Aug. 4, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its third quarter of fiscal 2022 ended June 30, 2022, on August 11, 2022 at 5:30 PM Eastern Time.

Conference Call and Webcast Information:

Thursday, August 11, 2022 ? 5:30 PM Eastern Time

Participant Dial-In:
877-407-8293 / +1 201-689-8349 

Live Webcast: 
https://event.choruscall.com/mediaframe/webcast.html?webcastid=DTR3sIOn

Phone Replay:
877-660-6853 / 201-612-7415, Access ID: 13732116; available through August 25, 2022

Webcast Replay:       
Available for 12 months

About NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. For more information, visit n1mtc.com.

SOURCE NeuroOne Medical Technologies Corporation


These press releases may also interest you

at 01:15
1st Epic Satoshi Auction Sold for $2.1 Million on CoinEx
The first-ever public auction of the epic satoshi held by CoinEx, the leading global cryptocurrency exchange, ended on April 25, 2024, at 16:00 (UTC). As the first example shown in history, the auction attracted global users for 35 bids, and the epic...

at 01:05
Peugeot Sport Aims for the Endurance Racing Finish Line With Simulation From Dassault Systèmes
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Peugeot Sport, the motorsports division of Stellantis, today announced their partnership to simulate and optimize the aerodynamics of the PEUGEOT 9X8 Hybrid Hypercar for the 2024 endurance...

at 00:39
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
ITRI Net Zero Day 2024 Showcases Hydrogen Innovation and Green Financing Solutions
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...

25 avr 2024
Identity Governance & Administration Market Projected to Reach $24.42 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

25 avr 2024
Contract Research Organization Services Market Projected to Reach $184.21 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

More news about Science and technology...


News published on and distributed by: